Thus, some BM resected under ipilimumab therapy showed dense infiltration of CD8+ cytotoxic tumor infiltrating lymphocytes (TILs) and FoxP3+ regulatory T cells, indicating a triggered immune response under therapy (35). The gene discussed is CD8A; the disease is neoplasm.